国际生殖健康/计划生育杂志 ›› 2025, Vol. 44 ›› Issue (3): 247-252.doi: 10.12280/gjszjk.20250004

• 综述 • 上一篇    下一篇

Fraser综合征病因和临床诊治的研究进展

刘静, 辛敏, 罗玉雷, 刘金秀()   

  1. 236600 安徽省亳州市妇幼保健院筛查中心(刘静);济南银丰医学检验所(辛敏,刘金秀);安徽省阜阳市妇幼保健计划生育服务中心检验科(罗玉雷)
  • 收稿日期:2025-01-03 出版日期:2025-05-15 发布日期:2025-06-04
  • 通讯作者: 刘金秀,E-mail:liujinxiu1987@163.com
  • 作者简介:审校者

Research Progress on Etiological Mechanism, Diagnosis and Treatment of Fraser Syndrome

LIU Jing, XIN Min, LUO Yu-lei, LIU Jin-xiu()   

  1. Screening Center, Bozhou Women and Children′s Health Hospital, Bozhou 236600, Anhui Province, China (LIU Jing); Jinan Yinfeng Medical Laboratory, Jinan 250000, China (XIN Min, LIU Jin-xiu); Department of Clinical Laboratory, Fuyang Maternal and Child Health and Family Planning Service Center, Fuyang 236000, Anhui Province, China (LUO Yu-lei)
  • Received:2025-01-03 Published:2025-05-15 Online:2025-06-04
  • Contact: LIU Jin-xiu, E-mail: liujinxiu1987@163.com

摘要:

Fraser综合征(Fraser syndrome,FS)是一种罕见的常染色体隐性遗传病,主要由Fras1/Frem蛋白复合物相关基因突变导致,与上皮-间充质结合紊乱密切相关。FS具有显著的临床和遗传异质性,表现为多发性先天性畸形,以隐眼、并指(趾)、肾发育不全、生殖器异常、喉闭锁等为典型特征。产前超声检查以羊水过少、肾发育不全等为主要表现。FS主要在胎儿和婴儿期发病,致残率、致死率高。目前,已知与FS相关的基因包括FRAS1、FREM2和GRIP1。临床上FS的诊断需综合临床症状、影像学检查和基因检测结果。尽管目前FS尚缺乏特异性治疗方法,但针对性的多学科干预和支持性治疗可改善患者预后。本文综述FS的临床特征、病因及发病机制、诊断、治疗等方面的研究进展,以期为FS的临床诊治提供参考。

关键词: Fraser综合征, 遗传性疾病, 表型, 诊断, FRAS1基因, FREM2基因, GRIP1基因

Abstract:

Fraser syndrome (FS), a rare autosomal recessive genetic disease, is primarily caused by the mutation in genes associated with the Fras1/Frem protein complex, which is closely related to the disruption of epithelial-mesenchymal interactions. With significant clinical and genetic heterogeneity, FS is characterized by multiple congenital malformations, and typical features such as cryptophthalmos, syndactyly, renal agenesis, ambiguous genitalia, and laryngeal atresia. Prenatal ultrasound typically reveals oligohydramnios and renal agenesis. FS predominantly manifests during fetal and infant stages, with high rates of disability and mortality. To date, the genes associated with FS include FRAS1, FREM2, and GRIP1. Clinical diagnosis of FS requires a comprehensive evaluation of symptoms, imaging examinations, and genetic testing. Although there is currently no specific treatment for FS, the targeted multidisciplinary interventions and supportive care can improve patient outcomes. This review summarizes the advances in the clinical characteristics, etiology, pathogenesis, diagnosis, and treatment of FS, aiming to provide valuable insights for its clinical management.

Key words: Fraser syndrome, Genetic diseases, Phenotype, Diagnosis, FRAS1 gene, FREM2 gene, GRIP1 gene